1. Home
  2. LOCO vs ATYR Comparison

LOCO vs ATYR Comparison

Compare LOCO & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo El Pollo Loco Holdings Inc.

LOCO

El Pollo Loco Holdings Inc.

HOLD

Current Price

$14.34

Market Cap

456.5M

ML Signal

HOLD

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.37

Market Cap

49.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LOCO
ATYR
Founded
1980
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
456.5M
49.2M
IPO Year
2014
2015

Fundamental Metrics

Financial Performance
Metric
LOCO
ATYR
Price
$14.34
$0.37
Analyst Decision
Buy
Hold
Analyst Count
4
9
Target Price
$14.17
$3.67
AVG Volume (30 Days)
170.8K
772.9K
Earning Date
05-07-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
4.65
6.98
EPS
0.70
N/A
Revenue
$401,701,000.00
$190,000.00
Revenue This Year
$3.60
N/A
Revenue Next Year
$3.98
N/A
P/E Ratio
$20.36
N/A
Revenue Growth
5.68
N/A
52 Week Low
$8.99
$0.36
52 Week High
$17.40
$1.12

Technical Indicators

Market Signals
Indicator
LOCO
ATYR
Relative Strength Index (RSI) 34.53 29.11
Support Level $13.52 N/A
Resistance Level $14.38 $0.59
Average True Range (ATR) 0.37 0.03
MACD -0.09 -0.01
Stochastic Oscillator 7.80 7.37

Price Performance

Historical Comparison
LOCO
ATYR

About LOCO El Pollo Loco Holdings Inc.

El Pollo Loco Holdings Inc operates and franchises hundreds of fast-casual chicken restaurants in the United States. It specializes in fire-grilling citrus-marinated chicken and operates in the limited service restaurant market segment. Its offerings include Mexican-inspired menu items, including burritos, tostadas, bowls, salads, and bone-in chicken meals in various portion sizes. It also offers citrus-marinated fire-grilled chicken, along with a range of salsas and dressings that allow customers to customize their meals. The company operates in one operating segment. The majority of the company's revenue is derived from company-operated restaurant revenue.

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

Share on Social Networks: